- Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection. Young, C.W., Schneider, R., Leyland-Jones, B., Armstrong, D., Tan, C.T., Lopez, C., Watanabe, K.A., Fox, J.J., Philips, F.S. Cancer Res. (1983)